1 Boehringer Ingelheim Pharma GmbH & Co. KG, Drug Discovery Sciences, Biberach an der Riß, Germany.
2 PureHoney Technologies, Billerica, MA, USA.
SLAS Technol. 2019 Aug;24(4):386-393. doi: 10.1177/2472630318822449. Epub 2019 Jan 30.
Label-free in vitro potency assays are an emerging field in drug discovery to enable more physiological conditions, to improve the readout quality, and to save time. For this approach mass spectrometry (MS) is a powerful technology to directly follow physiological processes. The speed of this methodology, however, was for a long time not compatible with chemiluminescence- or fluorescence-based assays. Recent advances in matrix-assisted laser desorption/ionization (MALDI) instrumentation paved the way for high-throughput MS analysis of label-free assays for large compound libraries, whereas electrospray ionization (ESI)-based mass spectrometers equipped with RapidFire autosamplers were limited to medium throughput. Here we present a technological advancement of the RapidFire device to enable cycle times of 2.5 s per sample. This newly developed BLAZE-mode substantially boosted the ESI-MS analysis speed, providing an alternative technology for label-free high-throughput screening.
无标记的体外效力测定是药物发现中的一个新兴领域,旨在实现更接近生理条件、改善读出质量和节省时间。为此,质谱(MS)是一种直接跟踪生理过程的强大技术。然而,这种方法的速度在很长一段时间内都与基于化学发光或荧光的测定法不兼容。基质辅助激光解吸/电离(MALDI)仪器的最新进展为高通量 MS 分析大型化合物文库的无标记测定法铺平了道路,而配备 RapidFire 自动进样器的电喷雾电离(ESI)质谱仪则限于中等通量。在这里,我们介绍了 RapidFire 设备的技术进步,使其每个样品的循环时间达到 2.5 秒。这种新开发的 BLAZE 模式极大地提高了 ESI-MS 分析速度,为无标记高通量筛选提供了一种替代技术。